Edited by: Irina Ielciu, University of Medicine and Pharmacy Iuliu Hatieganu, Romania
Reviewed by: Jian-Feng Tu, Beijing University of Chinese Medicine, China
Jie Zhan, Guangdong Provincial Hospital of Chinese Medicine, China
Xintong Yu, Shanghai University of Traditional Chinese Medicine, China
*Correspondence: Lin Yu,
†These authors have contributed equally to this work
‡ORCID: Peijing Rong,
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Most guidelines on insomnia focus more on the treatment of patients after the onset of the illness, with little elaboration on prevention before the onset of the illness. In particular, treatment of insomnia disorder using TCM preventive treatment is rarely mentioned. Therefore, to improve the rehabilitation and quality of life of patients with insomnia disorder and its high-risk groups, the Affiliated TCM Hospital of Guangzhou Medical University and the Institute of Acupuncture and Moxibustion, CACMS have jointly initiated the compilation of the “Practice guideline for TCM preventive treatment of Insomnia disorder”.
The guideline will adhere to the principles outlined in WHO Handbook for Guidelines Development, 2nd Edition by the World Health Organization and the
Based on the theoretical system of “TCM preventive treatment” of Chinese medicine this guideline is to construct a three-tier preventive framework. The development of this guideline can systematically integrate the characteristic techniques of TCM, such as physical identification, emotional regulation, acupuncture and massage, with the evidence-based evidence of modern sleep medicine, and build a new management model.
This guideline will serve as an evidence-based reference for standardized TCM preventive treatment methods, promoting the standardization and normative application of TCM preventive treatment in insomnia disorder. Ultimately, this guideline aims to improve the rehabilitation level and life quality of individuals with insomnia disorder and those at high risk of the disease.
Insomnia disorder is a sleep disorder characterized by frequent and persistent difficulty in falling asleep or maintaining sleep, which leads to inadequate sleep quality (
There is a lack of effective premorbid assessment and prevention methods for individuals with insomnia disorder. Insomnia involves complex interactions between psychological cognitive arousal and circadian rhythm and homeostasis mechanism changes (
Traditional Chinese Medicine (TCM) prioritizes preventative measures, aiming to intercept disease before its onset (“preventing illness before it occurs”) (
In 2016, Clinical practice guidelines (
Therefore, combined with the international diagnostic criteria and norms on insomnia disorder, absorbing the current research results and successful experience of traditional Chinese medicine in the prevention and treatment of insomnia, drawing on the research methods of clinical epidemiology, forming a clinical practice guideline for the prevention and treatment of insomnia disorder with evidence-based medical evidence is of great significance for improving the prevention and treatment of insomnia in the world and reducing the health and economic burden.
This clinical diagnosis and treatment guideline will refer to the relevant requirements of the WHO Guidelines Development Manual compiled by WHO and the TCM Guideline Development Program developed by the China Association of Chinese Medicine, and apply tools such as AGREE II (
This guideline will be co-sponsored by the Affiliated TCM Hospital of Guangzhou Medical University and the Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, with methodological support from the Institute of Health Data Science at Lanzhou University.
The guideline has been registered in English and Chinese at the Practice guideline REgistration for transPAREncy platform (PREPARE). The registration number is PREPARE-2023CN517.
Patients with insomnia disorder (primary insomnia, psychophysiological Insomnia and adjustment insomnia, excluding children’s sleep disorder and women’s sleep disorder at special times, as well as insomnia caused by definite internal medical, psychiatric, and neurological diseases) and those at high risk.
Clinicians of relevant departments, such as TCM preventive treatment Department, Psychiatry Department, Clinical Psychology Department, Traditional Chinese Internal Medicine Department, Integrated Chinese and Western Medicine Department, and Community Health Service Center.
The Guidelines Development Group will consist of the Guideline Steering Committee, the Guideline Consensus Expert Group, the Guideline Secretarial Group, the Guideline Evidence Evaluation Group, and the Guideline External Review Expert Group. The specific memberships and responsibilities are listed as below.
The Guideline Steering Committee will be composed of 9 experts(
Based on the consideration of geographical representation and gender, the Guideline Consensus Expert Group will consist of 20 experts in TCM preventive treatment Department, Encephalopathy Department, Psychiatry Department, and Department of Methodology for Evidence-Based Medicine. Main responsibilities: (1) Formulating and reviewing clinical questions and selecting outcomes; (2) Voting and consensus on recommendations; (3) Finalizing the full text of the guideline; In addition, the Guideline Consensus Expert Group will invite 1~2 patient representatives from the daily treatment patients to review the guideline manuscript. The expert group will provide a professional interpretation of the guidelines for the patients, and invite the patient representatives to provide comments and feedback on the summarized evidence and the formed recommendation using the perspective and identity of the ordinary patient.
The Guideline Secretarial Group will be composed of the staff of the Affiliated TCM Hospital of Guangzhou Medical University, which is the lead organization of the guideline. Main responsibilities: (1) Coordinate the work of other working groups; (2) Draft the guideline protocol; (3) Conduct investigate and research on clinical questions; (4) Organize consensus meetings on recommendations; (5) Document the whole process of guideline development; (6) Write the first draft of the guideline; (7) Submit the guideline for publication.
The Guideline Evidence Evaluation Group will be composed of professionals in evidence-based medicine from all units involved in guideline development who have been engaged in guideline evidence evaluation for at least 1 year. Main responsibilities: (1) Search, evaluate, synthesize, and grade evidence;(2) Create an summary of findings table (
The Guideline External Review Group shall be composed of 3-5 experts who have no conflict of interest with the guideline and are research in guideline-related fields. The main responsibilities: (1) Review of the finalized guideline in its entirety; (2) Propose specific comments and suggestions.
All members of the Guideline Steering Committee, the Consensus Expert Group, the Guideline
Secretarial Group, the Guideline Evidence Evaluation Group will be required to declare all potential conflicts of interest prior to formal participation in the development process or attendance at a meeting and completing a collecting disclosures of interest (COI) form, which includes both financial and non-financial aspects, to be retained by the Guidelines Working Group, and to The COI should be retained by the Guideline Working Group and agreed to be published in the Guideline. The declaration will include the absence of any commercial, professional or other interest in the subject matter of the guideline and any interest that may be affected by the results of the recommendations. If there is a relevant conflict of interest, it will be dealt with in accordance with the “COI management” (see
In the early stage, the Guideline Evidence Evaluation Group will use “insomnia
disorder” and “TCM preventive treatment” as the search terms to review the relevant literature in the Chinese and English databases, and at the same time, read textbooks and books as well as consult the websites of relevant societies to collect information; In addition, design clinician and patient questionnaires (
Formulating clinical questions: The first and second rounds will be scored on a 4-point scale, including the words “completely disagree”, “relatively disagree”, “relatively agree”, and “strongly agree”. The I-CVI (content validity index) will be calculated for each item, which is the number of experts who “relatively agree” and “strongly agree” for each item divided by the total number of experts participating in the evaluation, is the corresponding item level I-CVI, and requires I-CVI ≤ 0.78 as the exclusion criterion for selection (
Selecting outcomes: The importance ranking of the outcomes will be based on a 9-point scale, with 7 to 9 indicating critical to decision-making and recommendation (key outcome), 4 to 6 indicating important to decision-making and recommendation (important outcome), and 1 to 3 indicating of general importance to decision-making and recommendation (general outcome), with a total of two rounds of investigation and research work, and the confirmation of the outcomes will be completed in the third round.
Evidence search: The Patient, Intervention, Comparison, and Outcome (PICO) framework will be
constructed for each guideline key question, identifying the corresponding Chinese and English subject terms and free terms, respectively, and developing a search formula based on the search strategy of each data platform. Systematic search of databases such as PubMed, Embase, The Cochrane Library, Epistemonikos, Wanfang Data, China Knowledge Network (CNKI), and China Biomedical Literature Database (CBM) databases, and supplement with searching references from clinical trial registration platforms and retrospectively incorporated literature. The search will be conducted from the time of database construction to February 2025. Literature types include systematic reviews and original studies (randomized controlled trials, clinical trials, diagnostic trials, cohort studies, case-control studies, cross-sectional studies, and case series). An example of the search for “efficacy of acupuncture in the treatment of insomnia disorder” is shown in
Evidence screening and data extraction: The Guideline Evidence Evaluation Group will conduct the
search independently in groups of 2, and refer to the process shown in
Literature quality assessment: The Guideline Evidence Evaluation Group will assess the quality of the evidence separately, with assessment tools including AGREE II, AMSTAR 2, MINORS, CASP checklist, etc. The Guideline Evidence Evaluation Group will develop criteria for grading the quality of the evidence, and the assessment process will be done independently by the Guideline Evidence Evaluation Group in groups of 2, with any disagreements resolved through joint discussion or consultation with a third party, and low-quality evidence will be excluded. Randomized controlled trials, clinical trials, diagnostic trials, cohort studies, case-control studies, cross-sectional studies, and case series will be conducted using the Cochrane Risk of Bias Assessment Tool 2.0, ROBINS-I Tool (Risk of Bias In nonrandomized Studies-of Interventions), QUADAS-2 Tool (Quality Assessment of Diagnostic Accuracy Studies Quality of evidence), NOS scale (Newcastle-Ottawa Scale), AHRQ scale (Agency for Healthcare Research and Quality), and the Canadian Institute of Health Economics IHE Quality Assessment Tool.
Systematic review development and updating: If a key question has a high-quality systematic
review within three years, it is directly included; if a high-quality systematic review has been
published for more than three years, the high-quality systematic review is updated (
The GRADE (Grading of Recommendations Assessment, Development and Evaluation) (
Certainty of evidence and strength of recommendation grading citeria used in this guideline.
| Classification | Explicit description |
|---|---|
| Certainty of evidence | |
| High (A) | We are very confident that the true effect lies close to that of the estimate of the effec. |
| Moderate (B) | We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. |
| Low (c) | Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect. |
| Very low (D) | We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. |
| Recommended Strength | |
| Strongly Recommended/Strongly Not Recommended | Clearly show that the intervention does more good than harm or more harm than good |
| Weakly Recommended/Weakly Not Recommended | Uncertainty about the benefits and disadvantages or evidence of equal quality of benefits and disadvantages |
Possible recommendations will be formed based on the quality of evidence, balance of benefits and drawbacks, combined with patient preferences and values, and cost-effectiveness analysis. The recommendations will be classified into strong and weak recommendations (
Once the final recommendations are formulated, the Guideline Secretarial Group will write the full text of the guideline in accordance with the RIGHT-TCM items (
After the publication of the guideline, it will be introduced and disseminated through the self-media of the Affiliated Hospital of Traditional Chinese Medicine of Guangzhou Medical University, the Affiliated Brain Hospital of Guangzhou Medical University and related societies and academic conferences. The implementation of the guideline will be carried out through multi-center, large-sample, randomized controlled trials to verify and evaluate the clinical guidance value of the guideline.
This guideline is proposed to be updated once every 3 years (the timing may be adjusted to take into account the latest evidence), and the content of the update depends on whether new, high-quality medical evidence of relevance has appeared since the guideline was published, and whether there is an impact of the change in the evidence on the strength of the guideline’s recommendations; in addition, changes in patients’ wishes or demands will be collected during clinical practice. In the event of objections raised by the current or proposing revision team, a revised methodology plan will be presented to the organizing group or institutional platform for review and modification of the guideline. If no proposal is put forth near the review date, the lead organization will undertake the guideline update. This process will adhere to the internationally published Check List for the Reporting of Updated Guidelines (
Insomnia has shown a trend of high incidence and wide population. It has a wide impact on the physical and mental health, memory, innovative function and social activity function of the public (
Susceptibility (
Preventive and therapeutic measures for insomnia. “Chai Hu Long Gu Mu Li” Soup is very effective in preventing patients with qi depressive insomnia (
Pathological changes that occur in various parts of the body are reflected in the Auricular points.
Modern medicine shows that the auricle is rich in lymph, blood vessels, and nerves and intertwine with each other to form a network. Through the auricular acupuncture points, the acupoints are stimulated, causing the normal order of the brain reticular structure. stimulation, causing the normal orderly activation and inhibition of the brain reticulum structure, thus making the pathological sleep state to physiological sleep state. Guixiang Wen research team found that Applying Wang Bu Liu Xing to the subcortex of both ears, heart, Shen Men, sympathetic and other acupoints to prevent preoperative insomnia has significant therapeutic effect (
Compared with other interventions, there are several significant advantages of TCM preventive treatment. 1. Holistic view, treating both symptoms and root causes. TCM preventive treatment believes that insomnia is a manifestation of dysfunction of the internal organs (such as the heart, liver, kidneys and spleen) or disharmony of qi and blood, rather than a simple “sleep problem”. 2. Individualized diagnosis and treatment. Chinese medicine practitioners provide personalized solutions based on the patient’s constitution, symptoms and causes (e.g. heart-kidney incompatibility, liver depression and fire, heart-spleen deficiency, etc.). 3. Low side effects, suitable for long-term conditioning. Chinese medicine (natural herbs are the mainstay), with lower dependence compared to Western medicine, suitable for long-term conditioning of chronic insomnia patients.
The guideline is a clinical practice guideline with the theme of “insomnia”. The preliminary drafting plan can not only make the guideline drafting group familiar with the guideline developing process, but also standardize and transparent the work process, so as to improve the quality of this evidence-based application guideline and better serve patients (
There is no comprehensive guideline for the diagnosis and treatment of insomnia disorder using TCM preventive treatment, and such a guideline in needed.
Combined with the international diagnostic criteria and norms on insomnia disorder, absorbing the current research results and successful experience of traditional Chinese medicine in the prevention and treatment of insomnia, drawing on the research methods of clinical epidemiology, forming a clinical practice guideline for the prevention and treatment of insomnia disorder with evidence-based medical evidence.
It puts more emphasis on preventing disease, non-pharmacological therapies are evidence-based and optimized, and multimodal interventions are synergistic.
The inclusion of relevant literature published in Chinese and English.
This guideline intends to clarify the indications of different intervention measures and explore the advantages and disadvantages of different modes of combined application through comprehensive evidence retrieval, standardized evidence synthesis and evaluation, and scientific recommendation formation process, so as to standardize and guide the clinical application of preventive treatment of disease technology in TCM preventive treatment, reduce the occurrence of insomnia and prevent it from aggravation.
This review analyses existing studies and involves no patients or members of the public so ethics committee approval was not sought. The included studies must adhere to the Declaration of Helsinki and current ethical norms. The findings of this study will be disseminated through publication in a peer-reviewed journal or pertinent conference.
YD: Writing – review & editing. YW: Writing – review & editing. HY: Writing – original draft. YC: Writing – review & editing. SW: Writing – review & editing. PZ: Writing – review & editing. SG: Writing – review & editing. EL: Writing – review & editing. PR: Writing – review & editing. LY: Writing – review & editing.
The author(s) declare that financial support was received for the research and/or publication of this article. The relevant funds for the development of this guideline are from the National Administration of Traditional Chinese Medicine’s Traditional Chinese Medicine Inheritance and Innovation “Millions” Talent Project (Qihuang Project) Qihuang Scholars (National Traditional Chinese Medicine People’s Education [2021] No.203), Guangzhou Traditional Chinese Medicine Preventive Treatment Service Improvement Project (2023-2025), National Natural Science Foundation Project (81503475, 82004226), Guangzhou Health Science, Technology Major Project (2023A031002), Guangzhou Science and Technology Fund (2025A03J3510, 2025A03J3512), Project of Administration of Traditional Chinese Medicine of Guangdong Province (20251280, Guangzhou Health science and technology project (20242A011005) and Plan on enhancing scientific research in GMU (GMUCR2024-02030).
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
The Supplementary Material for this article can be found online at: